Altimmune, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.01 |
0.01 |
27.61 |
600.98 |
847.17 |
| Przychód Δ r/r |
0.00% |
382.09% |
-11.54% |
453026.55% |
2076.40% |
40.96% |
| Przychód (min) |
0.00 |
0.01 |
0.01 |
27.61 |
600.98 |
847.17 |
| Przychód (max) |
0.00 |
0.01 |
0.01 |
27.61 |
600.98 |
847.17 |
| EBITDA (średnia) |
-0.00 |
-0.00 |
-0.00 |
-16.57 |
-360.59 |
-508.30 |
| EBIT (średnia) |
-0.00 |
-0.00 |
-0.00 |
-16.57 |
-360.59 |
-508.30 |
| EBIT % |
-59.97% |
-59.99% |
-59.99% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-95.06 |
-87.85 |
-91.52 |
-84.79 |
217.98 |
303.66 |
| Zysk netto % |
-6651935.34% |
-1275288.66% |
-1501843.08% |
-307.06% |
36.27% |
35.84% |
| EPS (średnia) |
-1.35 |
-1.24 |
-1.31 |
-1.23 |
3.07 |
4.28 |
| Liczba analityków (Przychody) |
5 |
5 |
9 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
5 |
6 |
6 |
6 |
3 |
4 |
| symbol |
ALT |
ALT |
ALT |
ALT |
ALT |
ALT |